Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuki Ikeda

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 10, 2012
[Sodium glucose cotransporter inhibitors]Fuki Ikeda, Hirotaka Watada
Journal of Diabetes Investigation|May 21, 2014
Comparison of thrice-daily lispro 50/50 vs thrice-daily lispro in combination with sulfonylurea as initial insulin therapy for type 2 diabetesKeiko Yamashiro, Fuki Ikeda, Yoshio Fujitani, et al.
Journal of Diabetes Investigation|September 4, 2025
The Beck Depression Inventory-II scores of adults with type 1 diabetes in Japan: Analysis using the Juntendo-Aso Type 1 Diabetes (JAT-1) CohortFuki Ikeda, Junko Sato, Kenichi Nakajima, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 25, 2008
Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertensionShiho Nakayama, Hirotaka Watada, Tomoya Mita, et al.
Biochemical and Biophysical Research Communications|May 3, 2006
Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db miceJiaqing Shao, Noseki Iwashita, Fuki Ikeda, et al.
Endocrine Journal|July 21, 2007
Angiotensin II type 1 receptor blocker reduces monocyte adhesion to endothelial cells in spontaneously hypertensive ratsFuki Ikeda, Kosuke Azuma, Takeshi Ogihara, et al.
Diabetes Care|October 27, 2011
Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetesMichiko Yoshida, Tomoya Mita, Risako Yamamoto, et al.
Journal of Diabetes Investigation|November 8, 2024
Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR-QOL scores: An observational study of Japanese people with type 1 diabetes mellitusToshiki Kogai, Junko Sato, Haruna Yasuda, et al.
Journal of Diabetes Investigation|March 21, 2023
A 7 day inpatient diabetes education program improves quality of life and glycemic control 12 months after dischargeMika Kurita, Hiroaki Satoh, Hideyoshi Kaga, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 16, 2024
Protocol of a Prospective Observational Study on Lifestyle and Quality of Life in Adults with Type 1 Diabetes in JapanJunko Sato, Kenichi Nakajima, Tomoya Mita, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 10, 2012
[Sodium glucose cotransporter inhibitors]Fuki Ikeda, Hirotaka Watada
Journal of Diabetes Investigation|May 21, 2014
Comparison of thrice-daily lispro 50/50 vs thrice-daily lispro in combination with sulfonylurea as initial insulin therapy for type 2 diabetesKeiko Yamashiro, Fuki Ikeda, Yoshio Fujitani, et al.
Journal of Diabetes Investigation|September 4, 2025
The Beck Depression Inventory-II scores of adults with type 1 diabetes in Japan: Analysis using the Juntendo-Aso Type 1 Diabetes (JAT-1) CohortFuki Ikeda, Junko Sato, Kenichi Nakajima, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 25, 2008
Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertensionShiho Nakayama, Hirotaka Watada, Tomoya Mita, et al.
Biochemical and Biophysical Research Communications|May 3, 2006
Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db miceJiaqing Shao, Noseki Iwashita, Fuki Ikeda, et al.
Endocrine Journal|July 21, 2007
Angiotensin II type 1 receptor blocker reduces monocyte adhesion to endothelial cells in spontaneously hypertensive ratsFuki Ikeda, Kosuke Azuma, Takeshi Ogihara, et al.
Diabetes Care|October 27, 2011
Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetesMichiko Yoshida, Tomoya Mita, Risako Yamamoto, et al.
Journal of Diabetes Investigation|November 8, 2024
Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR-QOL scores: An observational study of Japanese people with type 1 diabetes mellitusToshiki Kogai, Junko Sato, Haruna Yasuda, et al.
Journal of Diabetes Investigation|March 21, 2023
A 7 day inpatient diabetes education program improves quality of life and glycemic control 12 months after dischargeMika Kurita, Hiroaki Satoh, Hideyoshi Kaga, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 16, 2024
Protocol of a Prospective Observational Study on Lifestyle and Quality of Life in Adults with Type 1 Diabetes in JapanJunko Sato, Kenichi Nakajima, Tomoya Mita, et al.
Pageof 4